US Patent Issued to The Board of Regents of the University of Oklahoma on June 3 for "Agonists of peroxisome proliferator-activated receptor alpha (PPARAlpha) and methods of use" (Oklahoma, Minnesota Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,708, issued on June 3, was assigned to The Board of Regents of the University of Oklahoma (Norman, Okla.).

"Agonists of peroxisome proliferator-activated receptor alpha (PPARAlpha) and methods of use" was invented by Adam Duerfeldt (Norman, Okla.), Xiaozheng Dou (Norman, Okla.) and Ziwei Hu (St. Paul, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Benzyl derivative compounds having peroxisome proliferator-activated receptor Alpha (PPARAlpha) agonistic activity, kits and compositions containing such compounds, and methods of their use in enhancing PPARAlpha activity for treating diseases and/or conditions involving inflammation and/or angiogenes...